[A Case of Unresectable Locally Advanced Pancreatic Cancer in Which Chemoradiotherapy Achieved Pathological Complete Response].

A 62-year-old man was diagnosed with unresectable locally advanced pancreatic cancer and was treated with mFOLFIRINOX for 9 months. Despite the tumor remarkable shrinkage, the contact with the nerve plexus around the SMA was not diminished. After confirming no distant metastasis with staging laparoscopy, radiotherapy with S-1 was performed. However, even after chemoradiotherapy, CT findings around the SMA showed no significant changes. Eleven months after the initial treatment, conversion surgery was conducted. The nerve plexus was successfully separated from the artery, allowing for a curative resection via pancreaticoduodenectomy. The histopathological findings revealed no residual cancer cells, and post-treatment classification was complete response. The patient remained healthy with no recurrence for over 13 months since the surgical resection. Preoperative CT findings sometimes suggest residual cancer around the nerve plexus even after treatment. However, as this case shows, the suspicion of residual cancer on imaging sometimes reveals no residual cancer, and the final decision may be determined by surgical resection.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-01
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[A Case of Unresectable Locally Advanced Pancreatic Cancer in Which Chemoradiotherapy Achieved Pathological Complete Response].

Takashi Tsuchiya, Tomoya Abe, Takayuki Morito, Tetsuya Kakita et al.
PubMed
Pancreatic and Hepatic Oncology Research
article

[A Case of Unresectable Locally Advanced Pancreatic Cancer in Which Chemoradiotherapy Achieved Pathological Complete Response].

Takashi Tsuchiya, Tomoya Abe, Takayuki Morito, Tetsuya Kakita, Masaya Oikawa, Kyohei Ariake, S. Nakayama
article en

Abstract

A 62-year-old man was diagnosed with unresectable locally advanced pancreatic cancer and was treated with mFOLFIRINOX for 9 months. Despite the tumor remarkable shrinkage, the contact with the nerve plexus around the SMA was not diminished. After confirming no distant metastasis with staging laparoscopy, radiotherapy with S-1 was performed. However, even after chemoradiotherapy, CT findings around the SMA showed no significant changes. Eleven months after the initial treatment, conversion surgery was conducted. The nerve plexus was successfully separated from the artery, allowing for a curative resection via pancreaticoduodenectomy. The histopathological findings revealed no residual cancer cells, and post-treatment classification was complete response. The patient remained healthy with no recurrence for over 13 months since the surgical resection. Preoperative CT findings sometimes suggest residual cancer around the nerve plexus even after treatment. However, as this case shows, the suspicion of residual cancer on imaging sometimes reveals no residual cancer, and the final decision may be determined by surgical resection.

PubMedVol. 51(13)
Sendai Shakai Hoken Hospital (JP)
Openalex Percentile: Top 57%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.